Retrospective Study
Copyright
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Endosc. Nov 16, 2022; 14(11): 704-717
Published online Nov 16, 2022. doi: 10.4253/wjge.v14.i11.704
Table 1 Clinical and pathological features of patients with colorectal cancer according to decompression methods
Characteristic 1 All cases (n = 102) Decompression methods P value 2 Transanal tube (n = 76) SEMS (n = 26) Sex, n (%) 0.91 Female 54 (53) 40 (53) 14 (54) Male 48 (47) 36 (47) 12 (46) Age, mean ± SD (years) 72.6 ± 12.5 71.7 ± 12.9 75.1 ± 11.1 0.24 Tumor location, n (%) 0.24 Cecum to transverse colon 16 (16) 13 (17) 3 (12) Descending to sigmoid colon 65 (64) 45 (59) 20 (77) Rectum 21 (21) 18 (24) 3 (12) Tumor size, mean ± SD (mm) 40.7 ± 16.2 39.0 ± 14.9 45.4 ± 19.3 0.086 Time from decompression to operation, mean ± SD (days) 13.6 ± 12.9 12.0 ± 7.6 18.2 ± 21.7 0.035 Histological type, n (%) 0.35 Well 29 (28) 19 (25) 10 (38) Moderate 67 (66) 53 (70) 14 (54) Mucinous, poor, or signet-ring cell 6 (5.9) 4 (5.3) 2 (7.7) T stage (depth of tumor invasion), n (%) 0.57 T1 (submucosa) - - - T2 (muscularis propria) 1 (1.0) - 1 (3.9) T3 (subserosa) 67 (66) 54 (71) 13 (50) T4 (serosa or other organs) 34 (33) 22 (29) 12 (46) N stage (number of positive lymph nodes), n (%) 0.54 N0 (0) 49 (48) 36 (47) 13 (50) N1 (1-3) 39 (38) 28 (37) 11 (42) N2 (4-) 14 (14) 12 (16) 2 (7.7) AJCC disease stage, n (%) 0.40 I 1 (1.0) - 1 (3.9) II 42 (41) 31 (41) 11 (42) III 36 (35) 27 (36) 9 (35) IV 23 (23) 18 (24) 5 (19) Mutation status, n (%) 0.51 KRAS mutated34 (43) 26 (47) 8 (33) NRAS mutated3 (3.8) 2 (3.6) 1 (4.2) BRAF mutated0 (0) 0 (0) 0 (0) Absent 42 (53) 27 (49) 15 (63)
Table 2 Perioperative features of patients with colorectal cancer according to decompression methods
Characteristic 1 All cases (n = 102) Decompression methods P value 2 Transanal tube (n = 76) SEMS (n = 26) Operation method, n (%) 0.31 Open 54 (53) 38 (50) 16 (62) Laparoscopy 48 (47) 38 (50) 10 (38) Conversion to laparotomy, n (%) 0.072 Absent 47 (98) 38 (100) 9 (90) Present 1 (2.1) - 1 (10) Procedure, n (%) 0.17 Colectomy 58 (57) 44 (58) 14 (54) Anterior resection 37 (36) 25 (33) 12 (46) Hartmann procedure 5 (4.9) 5 (6.6) - Abdominoperineal resection (Miles’ operation) 2 (2.0) 2 (2.6) - Lymph node dissection, n (%) 0.35 D1 3 (2.9) 3 (4.0) - D2 10 (9.8) 8 (11) 2 (7.7) D3 89 (87) 65 (86) 24 (92) Reconstruction (except 2 abdominoperineal resection cases), n (%) 0.011 Absent 10 (10) 10 (14) - Present 90 (90) 64 (86) 26 (100) Number of harvested lymph nodes, mean ± SD 21.6 ± 12.0 21.5 ± 11.8 21.7 ± 12.6 0.97 Operation time, mean ± SD (min) 241 ± 80 234 ± 79 263 ± 79 0.12 Blood loss, mean ± SD (g) 224 ± 364 229 ± 375 212 ± 336 0.84 Clavien-Dindo classification, n (%) 0.22 0 78 (76) 58 (76) 20 (77) 1 5 (4.9) 5 (6.6) - 2 11 (11) 8 (11) 3 (12) 3 7 (7.7) 5 (6.6) 2 (7.7) 4 - - - 5 1 (1.0) - 1 (3.9) Postoperative hospitalization, mean ± SD (days) 18.8 ± 15.1 19.3 ± 17.0 17.2 ± 6.7 0.53 Postoperative chemotherapy, n (%) 0.36 Absent 51 (50) 36 (47) 15 (58) Present 51 (50) 40 (53) 11 (42)
Table 3 Pathological features of patients with colorectal cancer according to decompression methods
Characteristic 1 All cases (n = 102) Decompression methods P value 2 , 3 Transanal tube (n = 76) SEMS (n = 26) Lymphatic invasion, n (%) 0.12 (0.020) Absent 11 (11) 10 (13) 1 (3.9) Minimal 41 (40) 33 (43) 8 (31) Moderate 32 (31) 23 (30) 9 (35) Severe 18 (18) 10 (13) 8 (31) Venous invasion, n (%) < 0.0001 (0.0002) Absent 19 (19) 17 (22) 2 (7.7) Minimal 45 (44) 37 (49) 8 (31) Moderate 23 (23) 19 (25) 4 (15) Severe 15 (15) 3 (4.0) 12 (46)
Table 4 Pathological features of patients with colorectal cancer according to decompression methods in strata of American Joint Committee on Cancer-pT stage or tumor location
Characteristic 1 All cases (n = 102) Decompression methods P value 2 , 3 Transanal tube (n = 76) SEMS (n = 26) Lymphatic invasion AJCC-pT2/T3 cases, n (%) 0.024 (0.036) Absent 8 (12) 8 (15) - Minimal 31 (46) 25 (46) 6 (43) Moderate 20 (29) 17 (31) 3 (21) Severe 9 (13) 4 (7.4) 5 (36) AJCC-pT4 cases, n (%) 0.53 (0.56) Absent 3 (8.8) 2 (9.1) 1 (8.3) Minimal 10 (29) 8 (36) 2 (17) Moderate 12 (35) 6 (27) 6 (50) Severe 9 (26) 6 (27) 3 (25) Venous invasion AJCC-pT2/T3 cases, n (%) 0.0031 (0.0025) Absent 13 (19) 12 (22) 1 (7.1) Minimal 37 (54) 32 (59) 5 (36) Moderate 12 (18) 9 (17) 3 (21) Severe 6 (8.8) 1 (1.9) 5 (36) AJCC-pT4 cases, n (%) 0.0077 (0.042) Absent 6 (18) 5 (23) 1 (8.3) Minimal 8 (24) 5 (23) 3 (25) Moderate 11 (32) 10 (45) 1 (8.3) Severe 9 (26) 2 (9.1) 7 (58) Lymphatic invasion Cecum to transverse colon cases, n (%) 0.21 (0.088) Absent 3 (19) 3 (23) - Minimal 7 (44) 6 (46) 1 (33) Moderate 4 (25) 4 (31) - Severe 2 (13) - 2 (67) Descending to rectum, n (%) 0.40 (0.096) Absent 8 (9.3) 7 (11) 1 (4.4) Minimal 34 (40) 27 (43) 7 (30) Moderate 28 (33) 19 (30) 9 (39) Severe 16 (19) 10 (16) 6 (26) Venous invasion Cecum to transverse colon cases, n (%) 0.10 (0.078) Absent 5 (31) 5 (38) - Minimal 6 (38) 5 (38) 1 (33) Moderate 2 (13) 2 (15) - Severe 3 (19) 1 (7.7) 2 (67) Descending to rectum, n (%) 0.0001 (0.0012) Absent 14 (16) 12 (19) 2 (8.7) Minimal 39 (45) 32 (51) 7 (30) Moderate 21 (24) 17 (27) 4 (17) Severe 12 (14) 2 (3.2) 10 (43)
Table 5 Logistic regression analyses to assess the association of decompression method (predictor) with severe venous invasion (outcome)
Model for severe venous invasion (n = 102, as a binary outcome variable) Univariable Multivariable 1 Multivariable 2 OR (95%CI) P value OR (95%CI) P value OR (95%CI) P value Decompression methods Transanal tube 1 (reference) < 0.0001 1 (reference) < 0.0001 1 (reference) < 0.0001 SEMS 20.9 (5.78-101) 19.4 (5.24-96.2) 36.7 (7.89-259) Age (for 10-yr increment) 1.29 (0.82-2.20) 0.28 Sex Female 1 (reference) 0.60 Male 1.34 (0.44-4.14) Tumor location Cecum to transverse colon 1 (reference) 0.27 1 (reference) 0.27 Descending to sigmoid colon 0.88 (0.23-4.31) 0.38 (0.05-2.60) Rectum 0.22 (0.01-1.90) 0.11 (0.003-1.58) Waiting period (for 1-wk increment) 0.91 (0.47-1.22) 0.64 Tumor size (for 10-mm increment) 1.10 (0.78-1.49) 0.55 Histological type Well 1 (reference) 0.21 1 (reference) 0.065 Moderate 2.65 (0.65-17.9) 7.27 (1.27-64.5) Mucinous, poor, or signet-ring cell 6.75 (0.66-72.0) 10.7 (0.48-342) AJCC-pT T2/T3 1 (reference) 0.021 1 (reference) 0.084 1 (reference) 0.082 T4 3.72 (1.22-12.2) 3.17 (0.86-12.6) 3.76 (0.85-19.4) Mutation Absent 1 (reference) 0.81 Present (KRAS , NRAS ) 1.16 (0.33-4.07)
Table 6 Pathological features of patients with colorectal cancer according to decompression methods (transanal tube vs 18-mm stent vs 22-mm stent)
Characteristic 1 All cases (n = 102) Decompression methods P value 2 , 3 Transanal tube (n = 76) 18 mm stent (n = 11) 22 mm stent (n = 15) Lymphatic invasion, n (%) 0.055 (0.0060) Absent 11 (11) 10 (13) 1 (9.1) - Minimal 41 (40) 33 (43) 5 (45) 3 (20) Moderate 32 (31) 23 (30) 4 (36) 5 (33) Severe 18 (18) 10 (13) 1 (9.1) 7 (47) Venous invasion, n (%) < 0.0001 (0.0006) Absent 19 (19) 17 (22) 2 (18) - Minimal 45 (44) 37 (49) 3 (27) 5 (33) Moderate 23 (23) 19 (25) 1 (9.1) 3 (20) Severe 15 (15) 3(4.0) 5 (45) 7 (47)
Citation: Kosumi K, Mima K, Kanemitsu K, Tajiri T, Takematsu T, Sakamoto Y, Inoue M, Miyamoto Y, Mizumoto T, Kubota T, Miyanari N, Baba H. Self-expanding metal stent placement and pathological alterations among obstructive colorectal cancer cases. World J Gastrointest Endosc 2022; 14(11): 704-717
URL: https://www.wjgnet.com/1948-5190/full/v14/i11/704.htm
DOI: https://dx.doi.org/10.4253/wjge.v14.i11.704